Literature DB >> 11598379

Estrogen modulation of the cyclic AMP response element-binding protein pathway. Effects of long-term and acute treatments.

L Carlstrom1, Z J Ke, J R Unnerstall, R S Cohen, S C Pandey.   

Abstract

Actions of estrogen include mechanisms leading to alterations in gene transcription that may be independent of nuclear estrogen receptors, as well as those involving direct action of the estrogen receptor on the genome. Also, the influence of estrogen in the brain appears to extend well beyond areas associated with reproduction and may include forebrain areas linked to affective and cognitive behaviors. We investigated the effects of acute and long-term estradiol benzoate (E2) treatment on total and phosphorylated cyclic AMP responsive element-binding (CREB) protein levels and on cyclic AMP response element (CRE)-DNA binding in forebrain areas of ovariectomized (OVX) rats. Long-term E2 treatment increased CRE-DNA binding in the amygdala but not in hippocampus, frontal cortex, or cerebellum. The increase in CRE-DNA binding in the amygdala was associated with increased levels of total and phosphorylated CREB (pCREB) protein during protracted E2 exposure. To localize the estrogenic effect in the amygdala and determine if an effect in one hippocampal region was masked by a lack of effect in another subregion, we performed immunolabeling of pCREB in brain structures of chronically treated OVX animals with or without E2. This treatment resulted in a significant increase in relative total immunolabeled nuclei in the anteroventral subdivision of the medial amygdala. In the hippocampus, a significant increase in relative total immunolabeled nuclei was seen in the CA1 and CA3 regions, but not in the dentate gyrus or hilus of the dentate gyrus. Acute E2 treatment resulted in increased CRE-DNA binding in the frontal cortex but not in amygdala, hippocampus, or cerebellum. However, no changes in levels of total CREB or pCREB protein were observed in the frontal cortex under E2 treatment. No changes were observed either in basal or cAMP-stimulated protein kinase A (PKA) activity or in PKA-alpha catalytic subunit immunoreactivity in the amygdala or the frontal cortex. Our study indicates that both long-term and acute treatments with estrogens influence the function of CREB in specific brain structures. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11598379     DOI: 10.1159/000054690

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  17 in total

Review 1.  Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling.

Authors:  Paul H Driggers; James H Segars
Journal:  Trends Endocrinol Metab       Date:  2002-12       Impact factor: 12.015

2.  Estrogen actions on neuroendocrine glia.

Authors:  Paul Micevych; Galyna Bondar; John Kuo
Journal:  Neuroendocrinology       Date:  2010-03-24       Impact factor: 4.914

Review 3.  Structure-nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds.

Authors:  Laszlo Prokai; James W Simpkins
Journal:  Pharmacol Ther       Date:  2007-02-02       Impact factor: 12.310

4.  Differential effects of acute progesterone administration on spatial and object memory in middle-aged and aged female C57BL/6 mice.

Authors:  Michael C Lewis; Patrick T Orr; Karyn M Frick
Journal:  Horm Behav       Date:  2008-05-27       Impact factor: 3.587

5.  SK3 channel expression during pregnancy is regulated through estrogen and Sp factor-mediated transcriptional control of the KCNN3 gene.

Authors:  Stephanie L Pierce; Sarah K England
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-08-03       Impact factor: 4.310

6.  Effects of estrogen treatment on expression of brain-derived neurotrophic factor and cAMP response element-binding protein expression and phosphorylation in rat amygdaloid and hippocampal structures.

Authors:  Jin Zhou; Huaibo Zhang; Rochelle S Cohen; Subhash C Pandey
Journal:  Neuroendocrinology       Date:  2005-09-21       Impact factor: 4.914

7.  Ovarian hormones and chronic administration during adolescence modify the discriminative stimulus effects of delta-9-tetrahydrocannabinol (Δ⁹-THC) in adult female rats.

Authors:  Peter J Winsauer; Catalin M Filipeanu; Evangeline M Bailey; Jerielle L Hulst; Jessie L Sutton
Journal:  Pharmacol Biochem Behav       Date:  2012-06-15       Impact factor: 3.533

8.  Psychophysical stress increases the expression of phospho-CREB, Fos protein and neurokinin-1 receptors in superficial laminae of trigeminal subnucleus caudalis in female rats.

Authors:  Sara L Duenes; Randy Thompson; Zheng Chang; Keiichiro Okamoto; David A Bereiter
Journal:  Neurosci Lett       Date:  2010-09-25       Impact factor: 3.046

9.  Expression of the nuclear receptor coactivator, cAMP response element-binding protein, is sexually dimorphic and modulates sexual differentiation of neonatal rat brain.

Authors:  Anthony P Auger; T S Perrot-Sinal; C J Auger; L A Ekas; M J Tetel; M M McCarthy
Journal:  Endocrinology       Date:  2002-08       Impact factor: 4.736

Review 10.  Non-feminizing estrogens: a novel neuroprotective therapy.

Authors:  Ashley B Petrone; Joshua W Gatson; James W Simpkins; Miranda N Reed
Journal:  Mol Cell Endocrinol       Date:  2014-01-11       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.